Clinical Case Reports (Oct 2021)

Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus

  • Panagiotis Pavlou,
  • Vaios Koutroukas,
  • Catherine Lissett,
  • Jamie C. Smith

DOI
https://doi.org/10.1002/ccr3.4830
Journal volume & issue
Vol. 9, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.

Keywords